465 related articles for article (PubMed ID: 12719202)
1. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population.
Sasser AC; Rousculp MD; Birnbaum HG; Oster EF; Lufkin E; Mallet D
Womens Health Issues; 2005; 15(3):97-108. PubMed ID: 15894195
[TBL] [Abstract][Full Text] [Related]
3. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.
Joish VN; Donaldson G; Stockdale W; Oderda GM; Crawley J; Sasane R; Joshua-Gotlib S; Brixner DI
Curr Med Res Opin; 2005 Apr; 21(4):535-44. PubMed ID: 15899102
[TBL] [Abstract][Full Text] [Related]
4. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
[TBL] [Abstract][Full Text] [Related]
5. Tegaserod treatment for IBS: a model of indirect costs.
Smith DG; Barghout V; Kahler KH
Am J Manag Care; 2005 Apr; 11(1 Suppl):S43-50. PubMed ID: 15926763
[TBL] [Abstract][Full Text] [Related]
6. Costs of care for irritable bowel syndrome patients in a health maintenance organization.
Levy RL; Von Korff M; Whitehead WE; Stang P; Saunders K; Jhingran P; Barghout V; Feld AD
Am J Gastroenterol; 2001 Nov; 96(11):3122-9. PubMed ID: 11721759
[TBL] [Abstract][Full Text] [Related]
7. Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
Martin BC; Ganguly R; Pannicker S; Frech F; Barghout V
Curr Med Res Opin; 2003; 19(8):771-80. PubMed ID: 14687449
[TBL] [Abstract][Full Text] [Related]
8. An employer perspective on annual employee and dependent costs for pediatric asthma.
Kleinman NL; Brook RA; Ramachandran S
Ann Allergy Asthma Immunol; 2009 Aug; 103(2):114-20. PubMed ID: 19739423
[TBL] [Abstract][Full Text] [Related]
9. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
10. Total costs of IBS: employer and managed care perspective.
Cash B; Sullivan S; Barghout V
Am J Manag Care; 2005 Apr; 11(1 Suppl):S7-16. PubMed ID: 15926759
[TBL] [Abstract][Full Text] [Related]
11. The direct and indirect cost burden of atopic dermatitis: an employer-payer perspective.
Fowler JF; Duh MS; Rovba L; Buteau S; Pinheiro L; Lobo F; Sung J; Doyle JJ; Swensen A; Mallett DA; Kosicki G
Manag Care Interface; 2007 Oct; 20(10):26-32. PubMed ID: 18405204
[TBL] [Abstract][Full Text] [Related]
12. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
[TBL] [Abstract][Full Text] [Related]
13. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States.
Brook RA; Wahlqvist P; Kleinman NL; Wallander MA; Campbell SM; Smeeding JE
Aliment Pharmacol Ther; 2007 Sep; 26(6):889-98. PubMed ID: 17767473
[TBL] [Abstract][Full Text] [Related]
14. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.
Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S
Epilepsia; 2010 May; 51(5):838-44. PubMed ID: 20002150
[TBL] [Abstract][Full Text] [Related]
16. Economic costs of benign prostatic hyperplasia in the private sector.
Saigal CS; Joyce G
J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787
[TBL] [Abstract][Full Text] [Related]
17. Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.
Kleinman NL; Brook RA; Doan JF; Melkonian AK; Baran RW
J Clin Psychiatry; 2009 Aug; 70(8):1098-104. PubMed ID: 19758521
[TBL] [Abstract][Full Text] [Related]
18. Indirect cost of ischemic heart disease to employers.
Guico-Pabia CJ; Murray JF; Teutsch SM; Wertheimer AI; Berger ML
Am J Manag Care; 2001 Jan; 7(1):27-34. PubMed ID: 11209448
[TBL] [Abstract][Full Text] [Related]
19. Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.
Chang S; Long SR; Kutikova L; Bowman L; Finley D; Crown WH; Bennett CL
J Clin Oncol; 2004 Sep; 22(17):3524-30. PubMed ID: 15337801
[TBL] [Abstract][Full Text] [Related]
20. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
Li X; Gignac MA; Anis AH
Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
